Inja Hong
About Inja Hong
Inja Hong is the Innovative Medicines Business Unit Lead at Bristol-Myers Squibb and the Cm Business Franchise Head at Novartis, with extensive experience in commercial excellence, strategy, and virology.
Title
Inja Hong serves as the Innovative Medicines Business Unit Lead at Bristol-Myers Squibb and the Cm Business Franchise Head at Novartis. His roles span continents, with responsibilities in both the United States and Switzerland.
Current Positions
Inja Hong currently holds two key positions in the pharmaceutical industry. At Novartis, he works as the Cm Business Franchise Head in Basel, Basel-city, Switzerland. Simultaneously, he leads the Innovative Medicines Business Unit at Bristol-Myers Squibb in New Jersey, United States.
Previous Roles at Bristol-Myers Squibb
Inja Hong held several important roles at Bristol-Myers Squibb. These include Specialty Care Business Unit Lead, Director of Virology Business Unit, Director of Commercial Excellence and Strategy, and Associate Director of Commercial Excellence and Strategy. His tenure at the company showcases his experience in business leadership and virology.
Career at IMS Health
Inja Hong also built a substantial career at IMS Health, where he worked from 2010 to 2014 in Danbury, Connecticut, United States. He started as a Senior Consultant and later became an Engagement Manager, focusing primarily on healthcare consulting.
Education and Expertise
Inja Hong studied at Seoul National University, where he received a Bachelor of Science in Pharmacy. He later pursued a Master of Business Administration at Duke University's Fuqua School of Business. His educational background supports his extensive experience in pharmaceutical management and commercial strategy.